Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-16

Clinical Trial Update: Feasibility Study of New Subcutaneous Glucose Sensor With Recording Devices [NA]

View source ↗

Summary

Feasibility study of a new subcutaneous glucose sensor with recording devices has completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Subcutaneous glucose sensor with recording devices (study product by Medtronic MiniMed, Inc.)

Snippet

Sponsor: Medtronic MiniMed, Inc. | Conditions: Type 1 Diabetes, Type 2 Diabetes | NA | Status: COMPLETED | Results posted: 2020-09-16